DrugDashboards

Ibandronate Sodium

Ibandronate Sodium · IBANDRONATE SODIUM 150 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited

NDC 65862-0237-26 · 2500 TABLET, FILM COATED in 1 BAG · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for ibandronate sodium (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ibandronate Sodium (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Golden State Medical Supply, Inc.IBANDRONATE SODIUM 150 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedIBANDRONATE SODIUM 150 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedIBANDRONATE SODIUM 150 mg/1Jul 15, 2026Aug 31, 2026
Apotex CorpIBANDRONATE SODIUM 150 mg/1Jul 15, 2026Jul 29, 2026
Apotex Corp.IBANDRONATE SODIUM 150 mg/1Jul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ibandronate Sodium — NDC 65862-0237-26," retrieved September 3, 2026, https://drugdashboards.com/drug/65862023726.

Free to cite with attribution — see how the data is put together.